What is the next step in managing cirrhosis with ascites?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Ascites in Cirrhosis

The first-line treatment for ascites in cirrhosis should be spironolactone alone, starting at 100 mg/day and increasing to a maximum of 400 mg/day if needed. 1

Initial Assessment and Management

When managing a patient with cirrhosis and ascites, the following steps should be implemented:

  1. Diagnostic paracentesis:

    • Obtain informed consent
    • Inoculate fluid into blood culture bottles at bedside
    • Examine fluid for neutrophil count
    • Calculate serum-ascites albumin gradient 2
  2. Dietary modifications:

    • Restrict dietary salt to 90 mmol/day (5.2 g salt/day) - no added salt diet 2, 1
    • Ensure adequate protein intake (1.2-1.5 g/kg/day) 1
  3. Pharmacological management:

    • Start spironolactone at 100 mg/day as the first-line agent 2, 1
    • Titrate dose upward as needed to a maximum of 400 mg/day 2, 3
    • If ascites fails to resolve with maximum spironolactone, add furosemide starting at 40 mg/day and increasing to a maximum of 160 mg/day 2, 1

Monitoring and Dose Adjustments

  • Monitor serum electrolytes, creatinine, and weight regularly 1
  • Target weight loss of 0.5 kg/day in patients without peripheral edema 1
  • Adjust diuretic dosing based on:
    • Response (weight loss and reduction in ascites)
    • Electrolyte abnormalities
    • Renal function

Management of Hyponatremia

Hyponatremia requires careful management based on severity:

  • Serum sodium 126-135 mmol/L with normal creatinine: Continue diuretics but monitor electrolytes closely; no water restriction needed 2, 1
  • Serum sodium 121-125 mmol/L with normal creatinine: Consider stopping diuretics or reducing dose 2, 1
  • Serum sodium 121-125 mmol/L with elevated creatinine: Stop diuretics and provide volume expansion 2, 1
  • **Serum sodium <120 mmol/L**: Stop diuretics; consider volume expansion with colloid or saline; avoid increasing serum sodium by >12 mmol/L per 24 hours 2, 1

Management of Refractory Ascites

For patients who fail to respond to maximum doses of diuretics (spironolactone 400 mg/day plus furosemide 160 mg/day) for at least one week:

  1. Therapeutic paracentesis:

    • First-line treatment for patients with large or refractory ascites 2
    • For paracentesis <5 liters: Follow with synthetic plasma expander (150-200 ml of gelofusine or haemaccel) 2
    • For large volume paracentesis: Administer albumin (8 g per liter of ascites removed) 2, 1
  2. Consider TIPS (Transjugular Intrahepatic Portosystemic Shunt):

    • For patients requiring frequent therapeutic paracentesis 2, 1
    • Use caution in patients with advanced age, elevated bilirubin, low platelets, high MELD score, or hepatic encephalopathy 1
  3. Liver transplantation evaluation:

    • All patients with ascites should be considered for liver transplantation evaluation 2, 1
    • Development of ascites is an important milestone indicating poor prognosis 2, 4

Common Pitfalls to Avoid

  • Starting with loop diuretics alone rather than spironolactone 1, 5
  • Excessive diuresis leading to renal dysfunction 1
  • Using NSAIDs, ACE inhibitors, or angiotensin receptor blockers, which can worsen ascites 1
  • Unnecessary water restriction in patients with uncomplicated ascites 2, 1
  • Failure to monitor electrolytes and renal function during diuretic therapy 1

Special Considerations

  • Spontaneous bacterial peritonitis (SBP): Patients recovering from SBP should receive prophylaxis with norfloxacin 400 mg/day or ciprofloxacin 500 mg once daily 2
  • Hepatorenal syndrome: Requires careful management with volume expansion and potentially vasoconstrictors 1
  • Tense ascites: Perform therapeutic paracentesis followed by diuretic therapy 1, 6

By following this algorithmic approach to managing ascites in cirrhosis, clinicians can optimize outcomes while minimizing complications, ultimately improving patient quality of life and potentially reducing mortality.

References

Guideline

Management of Ascites in Cirrhosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of ascites in patients with end-stage liver disease.

Reviews in gastroenterological disorders, 2004

Research

Medical treatment of ascites in cirrhosis.

Journal of hepatology, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.